Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Calprest NG

K-Number: K160447 · 2016-11-10

Decision Date2016-11-10
Product CodeNXO
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

Calprest NG is a medical device manufactured by Eurospital S.P.A.. It received FDA 510(k) clearance on 2016-11-10 under approval number K160447. The device is classified under product code NXO. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Calprest NG?

Calprest NG is a medical device that received FDA 510(k) clearance on 2016-11-10. It is manufactured by Eurospital S.P.A.. The 510(k) number is K160447.

When was Calprest NG approved by the FDA?

Calprest NG received FDA 510(k) clearance on 2016-11-10, under approval number K160447.

What company makes Calprest NG?

Calprest NG is manufactured by Eurospital S.P.A..

What is the FDA product code for Calprest NG?

The FDA product code for Calprest NG is NXO.

Other Devices by Eurospital S.P.A.

Related Devices (Code: NXO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.